Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Efficacy of ASP2151, a helicase-primase inhibitor, against thymidine kinase-deficient herpes simplex virus type 2 infection in vitro and in vivo.

Himaki T, Masui Y, Chono K, Daikoku T, Takemoto M, Haixia B, Okuda T, Suzuki H, Shiraki K.

Antiviral Res. 2012 Feb;93(2):301-4. doi: 10.1016/j.antiviral.2011.11.015. Epub 2011 Dec 4.

PMID:
22155691
2.

Helicase-primase inhibitors for herpes simplex virus: looking to the future of non-nucleoside inhibitors for treating herpes virus infections.

Biswas S, Sukla S, Field HJ.

Future Med Chem. 2014 Jan;6(1):45-55. doi: 10.4155/fmc.13.192. Review.

PMID:
24358947
3.

Antiviral drug resistance and helicase-primase inhibitors of herpes simplex virus.

Field HJ, Biswas S.

Drug Resist Updat. 2011 Feb;14(1):45-51. doi: 10.1016/j.drup.2010.11.002. Epub 2010 Dec 22. Review.

PMID:
21183396
4.

Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.

Piret J, Boivin G.

Antimicrob Agents Chemother. 2011 Feb;55(2):459-72. doi: 10.1128/AAC.00615-10. Epub 2010 Nov 15. Review.

5.

Helicase-primase as a target of new therapies for herpes simplex virus infections.

James SH, Larson KB, Acosta EP, Prichard MN.

Clin Pharmacol Ther. 2015 Jan;97(1):66-78. doi: 10.1002/cpt.3. Epub 2014 Nov 18. Review.

PMID:
25670384
6.

[Anti alpha-herpesvirus drugs].

Koshizuka T, Suzutani T.

Nihon Rinsho. 2012 Apr;70(4):558-63. Review. Japanese.

PMID:
22568134
7.

Helicase primase: targeting the Achilles heel of herpes simplex viruses.

Kleymann G.

Antivir Chem Chemother. 2004 May;15(3):135-40. Review.

PMID:
15266895
8.

The DNA helicase-primase complex as a target for herpes viral infection.

Weller SK, Kuchta RD.

Expert Opin Ther Targets. 2013 Oct;17(10):1119-32. doi: 10.1517/14728222.2013.827663. Epub 2013 Aug 12. Review.

9.
10.

Helicases as antiviral drug targets.

Frick DN.

Drug News Perspect. 2003 Jul-Aug;16(6):355-62. Review.

11.

The helicase-primase complex as a target for effective herpesvirus antivirals.

Field HJ, Mickleburgh I.

Adv Exp Med Biol. 2013;767:145-59. doi: 10.1007/978-1-4614-5037-5_7. Review.

PMID:
23161010
12.

VivaGel (SPL7013 Gel): a candidate dendrimer--microbicide for the prevention of HIV and HSV infection.

Rupp R, Rosenthal SL, Stanberry LR.

Int J Nanomedicine. 2007;2(4):561-6. Review.

13.

HSV antivirals - current and future treatment options.

Birkmann A, Zimmermann H.

Curr Opin Virol. 2016 Jun;18:9-13. doi: 10.1016/j.coviro.2016.01.013. Epub 2016 Feb 19. Review.

PMID:
26897058

Supplemental Content

Support Center